Enanta Sues Pfizer over Alleged Paxlovid Patent Infringement
Enanta Pharmaceuticals has filed a lawsuit against the pharma giant Pfizer over claims of patent infringement involving its COVID-19 treatment [...]
Pfizer Will Earn $16 Billion from Selling Shares in GSK Consumer Health Joint Venture
Pfizer has announced its exit from the consumer health market. In 2019, the company teamed up with Glaxo-Smith Klein (GSK), [...]
Pfizer Takes Heat for Alleged Pandemic Profiteering
Several patient advocacy groups have accused Pfizer of profiteering off the pandemic. The company, which made ~$26 billion at the [...]
Public Citizen Calls Out Pfizer’s “Patent Wall” for COVID-19 Treatment
Public Citizen has released a statement accusing Pfizer of filing a barrage of patents for a key component of their [...]
Pfizer Shifts to Virtual Meetings and Cuts Sales Staff
Pfizer will lay off sales staff as they pivot towards virtual sales meetings with providers to adjust to changing provider [...]
Pfizer and BioNTech Raise Price of COVID-19 Vaccine as UK Orders Booster Shots, Pfizer’s 2021 Sales Hit $11.3 Billion
Pfizer and BioNTech announced a price increase for COVID-19 booster shots—from £18 to £22. The European Union and the United [...]
Pfizer Heart Failure Medication Lawsuit Ruling Could Broadly Impact Medicare, Lead to Expensive Aduhelm Coverage
Pfizer is seeking legal backing for its plan to pay healthcare costs for Medicare patients taking one of its pricy [...]
Emergency Use Authorization for Pfizer’s Covid-19 Vaccine May do More Harm Than Good
Pfizer and BioNTech’s experimental Covid-19 vaccine candidate prevented more than 90% of infections in healthy volunteers. Based on these data, the companies [...]
Pfizer Seeks Judgment Favoring Proposed Patient-assistance Programs
If Pfizer wins their lawsuit against the U.S. government, Medicare stands to spend much, much more on some drugs. Pfizer [...]
COVID-19 Vaccine Pricing: Are the Manufacturers Signaling their Intent?
The Wall Street Journal is reporting that vaccine manufacturers are signaling the price for coronavirus vaccines, with prices ranging from [...]
Study Suggests Pfizer’s Vyndaqel is Too Expensive
A recent study published in JAMA Cardiology suggests the price tag on Pfizer's Vyndaqel is too high. According to a [...]
Pfizer CEO Says No ‘Huge Price’ Tag on Vaccine
Pfizer CEO Albert Bourla vowed the company would not "go huge prices" on a coronavirus vaccine, Axios reports. "If we [...]
Trump Administration Picks Five Companies in Operation Warp Speed
The Trump administration has selected five drugmakers as being most likely to develop a coronavirus vaccine, The New York Times [...]
FiercePharma Offering Live Updates to Coronavirus
FiercePharma is offering live updates of the coronavirus, as well as the goings-on in the pharmaceutical industry amid the outbreak. [...]
Pfizer Offers Its Resources in Fight Against Coronavirus
Pfizer is entering the fight against coronavirus after announcing it would offer its resources for wider use, FiercePharma reports. The [...]
COTA White Paper Spotlights Perspectives on RWE
A new white paper from COTA offers unique perspectives on real-world evidence (RWE), including input from Pfizer and Bristol-Myers Squibb [...]
AMCP Foundation Offering Oncology-Focused Internship
The Academy of Managed Care Pharmacy (AMCP) Foundation, in partnership with Pfizer, announced a new managed care internship focused on [...]
Concerto HealthAI Announces Funding, Partnerships at J.P. Morgan Conference
Concerto HealthAI during the J.P. Morgan Healthcare Conference announced it had secured $150 million in a new round of funding [...]
ICER Releases Final Report on JAK Inhibitors for RA
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 9, released its final report on JAK inhibitors for [...]
